Home/Filings/4/0000950170-24-073371
4//SEC Filing

Otero Jose Manuel 4

Accession 0000950170-24-073371

CIK 0001907108other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 9:04 AM ET

Size

7.3 KB

Accession

0000950170-24-073371

Insider Transaction Report

Form 4
Period: 2024-06-12
Otero Jose Manuel
Chief Technical Officer
Transactions
  • Award

    Common Stock

    2024-06-12+31,25031,250 total
  • Award

    Stock Option (Right to Buy)

    2024-06-12+187,500187,500 total
    Exercise: $18.19Exp: 2034-06-11Common Stock (187,500 underlying)
Footnotes (2)
  • [F1]The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]25% of the shares underlying the option shall vest on May 20, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

Documents

1 file

Issuer

Lexeo Therapeutics, Inc.

CIK 0001907108

Entity typeother

Related Parties

1
  • filerCIK 0002024096

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 9:04 AM ET
Size
7.3 KB